{
  "ticker": "EW",
  "last_updated": "2025-04-15T14:01:53.509490",
  "retention_years": 3,
  "count": 276,
  "transactions": [
    {
      "id": 52583,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 52526,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 52547,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 52573,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 52531,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 52571,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52535,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 52551,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 52562,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 52602,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 52553,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 52569,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52565,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52529,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52552,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52519,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52523,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52593,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 52524,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 27856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52598,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52563,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52603,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52520,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52527,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11983,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12004,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52521,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52550,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 11999,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52544,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12005,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52554,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11992,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52537,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12036,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52592,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 12032,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52588,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 11981,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52517,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 11985,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12020,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52525,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52575,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11993,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 27805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 52538,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 11988,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 27800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 52532,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 2297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12019,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52574,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 2298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11998,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 12021,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 27835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52543,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 52576,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 2317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 12026,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 12042,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 27840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 27859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 52581,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 52601,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 2290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12012,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52561,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 2294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 2309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 12016,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 12033,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12038,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 27830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 27847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 52568,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 52589,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52596,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 2278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11997,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52542,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 12018,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 27832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 52572,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 2288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 12010,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 27823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 52559,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 2301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 12024,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 27838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 52579,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 2268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 11982,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 27789,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 52518,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 2274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 2275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 2283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 2284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 2291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 2292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 2304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 2306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 2314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 11991,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 11994,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 12003,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 12006,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 12013,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 12014,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 12027,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 12029,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 12039,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 27803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 27806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 27815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 27819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 27827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 27828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 27841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 27843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 27855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 52536,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 52539,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 52549,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 52555,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 52564,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 52566,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 52582,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 52585,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 52597,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 2276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 11995,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 27807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 52540,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 2270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 2271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 2273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 2282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 2286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 2300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 2302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 2311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 2315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 11986,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 11987,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 11990,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 12002,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 12008,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 12023,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 12025,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 12035,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 12040,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 27798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 27799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 27802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 27814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 27821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 27837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 27839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 27849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 27857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 52528,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 52530,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 52534,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 52548,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 52557,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 52578,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 52580,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 52591,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 52599,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 2269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 2272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 2285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 2287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 2293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 2318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 11984,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 11989,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 12001,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 12007,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 12009,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 12015,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 12034,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 12043,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 27793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 27801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 27813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 27820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 27822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 27829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 27848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 27861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 52522,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 52533,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 52546,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 52556,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 52558,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 52567,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 52590,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 52604,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 2267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 2277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 2280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 2295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 2305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 2308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 2312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 2316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 11980,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 11996,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 12000,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 12017,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 12028,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 12031,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 12037,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 12041,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 27787,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 27808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 27812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 27831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 27842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 27845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 27852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 27858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 52516,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 52541,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 52545,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 52570,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 52584,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 52587,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 52594,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 52600,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 2307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 12030,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 27844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 52586,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 2289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 12011,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 27824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 52560,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    }
  ]
}